Duncan Charles Cliff bought VNDA
April 22, 2026 · Form 4 insider transaction
Duncan Charles Cliff bought 57,101 shares of Vanda Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
57,101
Price
$0.00
Total value
N/A
InsiderDuncan Charles Cliff
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 22, 2026
Filing dateApril 24, 2026
Shares owned after57,101
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on April 22, 2027, provided the Reporting Person has provided continuous service to the Issuer through each annual vesting date.